Delivery Order SPE2DR25D1205-SPE2DR26F0XE9
- Not listed
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,637.01 on December 1, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $3,161.04. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $18,476.36 for Mounjaro 5 mg/0.5 mL pens on December 5, 2025, with a completion date of December 8, 2025. This firm fixed-price contract, which is not set-aside, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order is for pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,302.77 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on November 14, 2025, with completion targeted for November 17, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $8,690.90 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle, leveraging the company's established relationship with the...
- The Defense Logistics Agency awarded a $10,586.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on November 3, 2025, with completion scheduled for November 4, 2025. This is a non-set-aside contract issued as a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $2,750.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pens on September 11, 2025, with completion scheduled for September 12, 2025. This non-set-aside award was made competitively and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.68 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens (0.5 mL) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,419.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract with an ultimate completion date of June 17, 2025 will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0XE9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,549.34 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on November 25, 2025, with completion targeted for November 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is one of numerous pharmaceutical procurements AmerisourceBergen fulfills through its comprehensive prime vendor contract with the Defense Logistics Agency, which supplies military healthcare systems and other federal agencies with a broad range of medications, vaccines, and medical supplies. Mounjaro, a diabetes medication, falls within the extensive therapeutic portfolio the company provides to support Department of Defense health programs globally. AmerisourceBergen's position as a primary pharmaceutical distributor for federal medical procurement underscores the company's critical role in sustaining military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/24/25 |